{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T22:15:48Z","timestamp":1783116948929,"version":"3.54.6"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007258","name":"SUNY The State University of New York","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007258","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005205","name":"Johnson & Johnson Innovative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"US Office of Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012331","name":"Agentschap Innoveren en Ondernemen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002913","name":"Vlaamse Regering","doi-asserted-by":"publisher","award":["HBC.2022.0661"],"award-info":[{"award-number":["HBC.2022.0661"]}],"id":[{"id":"10.13039\/501100002913","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ijid.2026.108771","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:45:50Z","timestamp":1778759150000},"page":"108771","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Dengue antibody dynamics resolved at epitope level using a dengue 1 human infection model"],"prefix":"10.1016","volume":"169","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-1962-7836","authenticated-orcid":false,"given":"Johanna","family":"Bouckaert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam T.","family":"Waickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin K.","family":"Ari\u00ebn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Lagatie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2026.108771_bib0001","doi-asserted-by":"crossref","unstructured":"Wilder-Smith A, Ooi EE, Horstick O, WB Dengue. The Lancet. 2019;393(10169):350\u201363. doi:10.1016\/S0140-6736(18)32560-1.","DOI":"10.1016\/S0140-6736(18)32560-1"},{"issue":"2","key":"10.1016\/j.ijid.2026.108771_bib0002","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/infdis\/jiaa351","article-title":"A phase 1, open-label assessment of a dengue virus-1 live virus Human challenge strain","volume":"223","author":"Endy","year":"2021","journal-title":"J Infect Dis"},{"issue":"668","key":"10.1016\/j.ijid.2026.108771_bib0003","doi-asserted-by":"crossref","first-page":"eabo5019","DOI":"10.1126\/scitranslmed.abo5019","article-title":"Evolution of inflammation and immunity in a dengue virus 1 human infection model","volume":"14","author":"Waickman","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ijid.2026.108771_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105728","article-title":"Quantifying temporal differences in the induction of interferon-mediated signalling observed in a dengue virus 1 human infection model: insights from longitudinal proteome analysis","volume":"115","author":"Struyfs","year":"2025","journal-title":"eBioMedicine"},{"key":"10.1016\/j.ijid.2026.108771_bib0005","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.686691","article-title":"Dynamics of the magnitude, breadth and depth of the antibody response at epitope level following dengue infection","volume":"12","author":"Falconi-Agapito","year":"2021","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.ijid.2026.108771_bib0006","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1093\/infdis\/jiaa018","article-title":"Using NS1 flavivirus protein microarray to infer past infecting dengue virus serotype and number of past dengue virus infections in Vietnamese individuals","volume":"223","author":"Thao","year":"2021","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.ijid.2026.108771_bib0007","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00095-18","article-title":"Diagnosis of Zika Virus infection by peptide array and enzyme-linked immunosorbent assay","volume":"9","author":"Mishra","year":"2018","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.ijid.2026.108771_bib0008","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/1743-422X-11-174","article-title":"Antibodies reacting with JCPyV_VP2 _167-15mer as a novel serological marker for JC polyomavirus infection","volume":"11","author":"Lagatie","year":"2014","journal-title":"Virol J"},{"issue":"4","key":"10.1016\/j.ijid.2026.108771_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009369","article-title":"Identification of antigenic linear peptides in the soil-transmitted helminth and Schistosoma mansoni proteome","volume":"15","author":"Vlaminck","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijid.2026.108771_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.710551","article-title":"Linear and continuous flavivirus epitopes from naturally infected humans","volume":"11","author":"Fumagalli","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"10.1016\/j.ijid.2026.108771_bib0011","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3390\/vaccines8020174","article-title":"When can one vaccinate with a live vaccine after wild-type dengue infection?","volume":"8","author":"Guy","year":"2020","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.ijid.2026.108771_bib0012","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s44298-025-00114-z","article-title":"Flavivirus infections and diagnostic challenges for dengue, West Nile and Zika viruses","volume":"3","author":"Madere","year":"2025","journal-title":"Npj Viruses"},{"key":"10.1016\/j.ijid.2026.108771_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1200195","article-title":"Dengue virus neutralizing antibody: a review of targets, cross-reactivity, and antibody-dependent enhancement","volume":"14","author":"Sarker","year":"2023","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.ijid.2026.108771_bib0014","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.3390\/v3122374","article-title":"The Human antibody response to Dengue virus infection","volume":"3","author":"Wahala","year":"2011","journal-title":"Viruses."},{"issue":"11","key":"10.1016\/j.ijid.2026.108771_bib0015","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/trstmh\/trz068","article-title":"A review of dengue diagnostics and implications for surveillance and control","volume":"113","author":"Raafat","year":"2019","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.ijid.2026.108771_bib0016","doi-asserted-by":"crossref","first-page":"975398","DOI":"10.3389\/fcimb.2022.975398","article-title":"Serological cross-reactivity among common flaviviruses","volume":"12","author":"Chan","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"6","key":"10.1016\/j.ijid.2026.108771_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178009","article-title":"Natural antibody responses to the capsid protein in sera of Dengue infected patients from Sri Lanka","volume":"12","author":"Nadugala","year":"2017","journal-title":"PLOS ONE"},{"issue":"2","key":"10.1016\/j.ijid.2026.108771_bib0018","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4161\/mabs.1.2.7908","article-title":"Monoclonal antibody to dengue capsid protein: its application in dengue studies","volume":"1","author":"Vazquez","year":"2009","journal-title":"mAbs"},{"issue":"1\u20132","key":"10.1016\/j.ijid.2026.108771_bib0019","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.virusres.2005.03.022","article-title":"The identification of immunodominant linear epitopes of dengue type 2 virus capsid and NS4a proteins using pin-bound peptides","volume":"112","author":"AnandaRao","year":"2005","journal-title":"Virus Res"},{"issue":"8","key":"10.1016\/j.ijid.2026.108771_bib0020","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00705-009-0426-5","article-title":"Production and characterization of anti-dengue capsid antibodies suggesting the N terminus region covering the first 20 amino acids of dengue virus capsid protein is predominantly immunogenic in mice","volume":"154","author":"Puttikhunt","year":"2009","journal-title":"Arch Virol"},{"key":"10.1016\/j.ijid.2026.108771_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00388","article-title":"Dengue serotype cross-reactive, anti-E protein antibodies confound specific immune memory for 1 year after infection","volume":"5","author":"Toh","year":"2014","journal-title":"Front Immunol."},{"issue":"9","key":"10.1016\/j.ijid.2026.108771_bib0022","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1128\/JVI.02458-10","article-title":"The unique transmembrane hairpin of flavivirus fusion protein E is essential for membrane fusion","volume":"85","author":"Fritz","year":"2011","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.ijid.2026.108771_bib0023","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3390\/v9110338","article-title":"Structures and functions of the envelope glycoprotein in flavivirus infections","volume":"9","author":"Zhang","year":"2017","journal-title":"Viruses"},{"issue":"18","key":"10.1016\/j.ijid.2026.108771_bib0024","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01023-18","article-title":"Engineered dengue virus domain III proteins elicit cross-neutralizing antibody responses in mice","volume":"92","author":"Frei","year":"2018","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.ijid.2026.108771_bib0025","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1021\/acsinfecdis.4c00058","article-title":"An engineered N-glycosylated dengue envelope protein domain III facilitates epitope-directed selection of potently neutralizing and minimally enhancing antibodies","volume":"10","author":"Nilchan","year":"2024","journal-title":"ACS Infect Dis"},{"issue":"8","key":"10.1016\/j.ijid.2026.108771_bib0026","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.3390\/ijms20081921","article-title":"Computational analysis of Dengue Virus envelope protein (E) reveals an epitope with flavivirus immunodiagnostic potential in peptide microarrays","volume":"20","author":"Bergamaschi","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.ijid.2026.108771_bib0027","doi-asserted-by":"crossref","DOI":"10.1038\/srep18077","article-title":"Enhanced performance of an innovative dengue IgG\/IgM rapid diagnostic test using an anti-dengue EDI monoclonal antibody and dengue virus antigen","volume":"5","author":"Lee","year":"2015","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.ijid.2026.108771_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0292451","article-title":"Linear epitope mapping in the E and NS1 proteins of dengue and Zika viruses: prospection of peptides for vaccines and diagnostics","volume":"18","author":"Aquino","year":"2023","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ijid.2026.108771_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/1820325","article-title":"Detection of Dengue virus-specific IgM and IgG antibodies through peptide sequences of envelope and NS1 proteins for serological identification","volume":"2020","author":"Nagar","year":"2020","journal-title":"J Immunol Res"},{"issue":"9","key":"10.1016\/j.ijid.2026.108771_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007747","article-title":"High specificity and sensitivity of Zika EDIII-based ELISA diagnosis highlighted by a large human reference panel","volume":"13","author":"Denis","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijid.2026.108771_bib0031","doi-asserted-by":"crossref","unstructured":"Roehrig JT, Bolin RA, Kelly RG Monoclonal antibody mapping of the envelope glycoprotein of the Dengue 2 Virus, Jamaica. Virology. 1998;246(2):317\u201328. doi:10.1006\/viro.1998.9200.","DOI":"10.1006\/viro.1998.9200"},{"issue":"1","key":"10.1016\/j.ijid.2026.108771_bib0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00430-021-00726-1","article-title":"Discovery of B-cell epitopes for development of dengue vaccines and antibody therapeutics","volume":"211","author":"Anasir","year":"2022","journal-title":"Med Microbiol Immunol"},{"issue":"1\u20132","key":"10.1016\/j.ijid.2026.108771_bib0033","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.vetimm.2012.08.006","article-title":"A T-cell epitope on NS3 non-structural protein enhances the B and T cell responses elicited by dendrimeric constructions against CSFV in domestic pigs","volume":"150","author":"Tarradas","year":"2012","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.ijid.2026.108771_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2023.199292","article-title":"IgM-specific linear epitopes on the E2 protein for serodiagnosis of Chikungunya","volume":"339","author":"Li","year":"2024","journal-title":"Virus Res"},{"issue":"15","key":"10.1016\/j.ijid.2026.108771_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2023.06.023","article-title":"Structures of dengue virus RNA replicase complexes","volume":"83","author":"Osawa","year":"2023","journal-title":"Mol Cell"},{"issue":"4","key":"10.1016\/j.ijid.2026.108771_bib0036","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1074\/jbc.M114.607341","article-title":"The C-terminal 50 amino acid residues of Dengue NS3 protein are important for NS3-NS5 interaction and viral replication","volume":"290","author":"Tay","year":"2015","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.ijid.2026.108771_bib0037","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3390\/membranes12020231","article-title":"Structures and dynamics of Dengue Virus nonstructural membrane proteins","volume":"12","author":"Li","year":"2022","journal-title":"Membranes"},{"issue":"5","key":"10.1016\/j.ijid.2026.108771_bib0038","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.3390\/v15051102","article-title":"Identification of key residues in dengue virus NS1 protein that are essential for its secretion","volume":"15","author":"Tan","year":"2023","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.ijid.2026.108771_bib0039","doi-asserted-by":"crossref","first-page":"6975","DOI":"10.1038\/s41598-017-07308-3","article-title":"Antibodies against modified NS1 wing domain peptide protect against Dengue virus infection","volume":"7","author":"Lai","year":"2017","journal-title":"Sci Rep."},{"issue":"1","key":"10.1016\/j.ijid.2026.108771_bib0040","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.55","article-title":"Dengue infection","volume":"2","author":"Guzman","year":"2016","journal-title":"Nat Rev Dis Primer"},{"issue":"10","key":"10.1016\/j.ijid.2026.108771_bib0041","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.4049\/jimmunol.1700029","article-title":"Antibody epitopes identified in critical regions of Dengue virus nonstructural 1 protein in mouse vaccination and natural Human infections","volume":"198","author":"Hertz","year":"2017","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.ijid.2026.108771_bib0042","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1128\/CVI.00371-06","article-title":"Antibody responses are generated to immunodominant ELK\/KLE-type motifs on the nonstructural-1 glycoprotein during live Dengue Virus infections in mice and humans: implications for diagnosis, pathogenesis, and vaccine design","volume":"14","author":"Falconar","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.ijid.2026.108771_bib0043","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jviromet.2018.04.009","article-title":"Development of antibody biomarkers of long term and recent dengue virus infections","volume":"257","author":"Nascimento","year":"2018","journal-title":"J Virol Methods"},{"issue":"1","key":"10.1016\/j.ijid.2026.108771_bib0044","doi-asserted-by":"crossref","first-page":"21548","DOI":"10.1038\/s41598-022-26097-y","article-title":"Differential critical residues on the overlapped region of the non-structural protein-1 recognized by flavivirus and dengue virus cross-reactive monoclonal antibodies","volume":"12","author":"Luangaram","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijid.2026.108771_bib0045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.793882","article-title":"Peptide biomarkers for the diagnosis of dengue infection","volume":"13","author":"Falconi-Agapito","year":"2022","journal-title":"Front Immunol"},{"issue":"39","key":"10.1016\/j.ijid.2026.108771_bib0046","doi-asserted-by":"crossref","first-page":"16922","DOI":"10.1073\/pnas.1010867107","article-title":"Immunodominant T-cell responses to dengue virus NS3 are associated with DHF","volume":"107","author":"Duangchinda","year":"2010","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"10.1016\/j.ijid.2026.108771_bib0047","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2023.2279355","article-title":"Lambda-free light chain: a serum marker of dengue disease via NS3 protease-mediated antibody cleavage","volume":"14","author":"Wang","year":"2023","journal-title":"Virulence"},{"issue":"11","key":"10.1016\/j.ijid.2026.108771_bib0048","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.it.2016.08.010","article-title":"Present yourself! by MHC class I and MHC class II molecules","volume":"37","author":"Rock","year":"2016","journal-title":"Trends Immunol"},{"issue":"suppl 2","key":"10.1016\/j.ijid.2026.108771_bib0049","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1093\/infdis\/jiu112","article-title":"Dengue Human infection model performance parameters","volume":"209","author":"Endy","year":"2014","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2026.108771_bib0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009240","article-title":"Temporally integrated single cell RNA sequencing analysis of PBMC from experimental and natural primary human DENV-1 infections","volume":"17","author":"Waickman","year":"2021","journal-title":"PLOS Pathog"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226004066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226004066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:21:19Z","timestamp":1783113679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226004066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":50,"alternative-id":["S1201971226004066"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108771","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dengue antibody dynamics resolved at epitope level using a dengue 1 human infection model","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108771","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108771"}}